You are overlooking the fact that the shares of Akebia are much higher. So we are getting the potential of their drug and hopefully much less in overall costs. I think it is good overall.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.